简要的B细胞HLA表皮图的历史
Ilias Doxiadis1, Henry Loeffler-Wirth2, Nils Lachmann3
1Laboratory for Transplantation Immunology, University Hospital Leipzig, Faculty of Medicine Leipzig, Leipzig, Germany.
概括
定义人类白细胞抗原 (HLA) 表位对移植免疫遗传学至关重要,因为HLA等位基因的数量庞大. 目前的方法面临挑战,但了解这些表位是推动抗体查和患者特异反应分析的关键.
科学领域:
- 移植免疫遗传学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 人类白细胞抗原 (HLA) 系统非常复杂,有超过38000个等位基因,这对移植提出了挑战.
- 当前的HLA类型化方法,如下一代测序,可以识别多个等位基因.
- 对HLA抗体的查受限于缺乏代表所有已知的等位基因的特定标珠.
研究的目的:
- 详细阐述目前对HLA表位的知识.
- 通过定义特定的标表位,解决HLA抗体查的挑战.
- 讨论在HLA表位研究中使用eplet进行统计分析.
主要方法:
- 审查关于HLA类I和II表现现现的当前知识.
- 鉴定抗体确认的表位 (72对于HLA类I,74对于HLA类II).
- 讨论基于eplet的统计分析.
主要成果:
- 已经确定了一组定义的HLA表位,对HLA类I和II的特定计数.
- 埃普莱特提供了一种用于统计分析HLA表位数据的方法.
- 这些HLA表位的绝对定义尚未建立.
结论:
- 了解HLA表位对推进移植免疫遗传学和抗体查至关重要.
- 爱普莱特分析提供了关联性见解,但需要进一步验证.
- 为了全面了解HLA表位,需要持续合作,因为反应性仍然是患者特异性的.
相关概念视频
Antigens Involved in Adaptive Immunity
483
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
483
Hybridoma Technology
14.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.4K
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Diversity of Antigen Receptors
566
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
566
Cross-reactivity
31.0K
Overview
31.0K
Antigen Processing Pathways
989
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
989


